Systems and methods for controlling a pump system for use in negative pressure wound therapy are described herein. In some embodiments, a method for controlling a pump system includes causing provision of negative pressure, via a flow path, to a wound dressing configured to be positioned over a wound, the flow path configured to fluidically connect the pump system to the wound dressing, measuring a first pressure value in the flow path at a first time, measuring a second pressure value in the flow path at a second time, calculating a first rate of pressure change using the first and second pressure values, and in response to determining that the calculated first rate of pressure change satisfies a threshold rate of change, providing an indication that the wound dressing is full, wherein the method is performed under control of a controller of the pump system.

A patient interface for delivery of a supply of pressurised air or breathable gas to an entrance of a patient's airways includes a frame member, a cushion assembly provided to the frame member, and an anterior wall member repeatedly engageable with and disengageable from the cushion assembly. The frame member includes connectors operatively attachable to a positioning and stabilizing structure. The cushion assembly includes a seal-forming structure and a void defined by an anterior surface of the cushion assembly. The anterior wall member has a predetermined surface area to seal the void of the cushion assembly and form a gas chamber when the anterior wall member and the cushion assembly are engaged. The void of the cushion assembly is sized such that the patient's nose and/or mouth is substantially exposed when the anterior wall member is disengaged from the cushion assembly thereby improving breathing comfort of the patient.

System (100) comprising a device (101) comprising a body (102), an ion conductive member (120), a first electrode (131), and a second electrode (132). The system (100) further comprises a source solution (141), a target solution (142), a first species (151), and a second species (152). A first end (121) of the ion conductive member (120) is arranged in contact with 5 the source solution (141). A second end (122) of the ion conductive member (120) is arranged in contact with the target solution (142). The first electrode (131) is arranged in contact with the source solution (141), the second electrode (132) is arranged in contact with the target solution (142), the first species (151) is in the source solution (141), and the second species (152) is in the target solution (142). Under the influence of an electrical field, the first species (151) is 10 transported through the ion conductive member (120) from the source solution (141) to the target solution (142) and interacts with the second species (152), such that at least one part (153) of the second species (152) is released.

This invention pertains to systems and components useful for infusing medications such as insulin. Typically, the components are used to deliver insulin to a diabetic patient at a site of infusion over a period of time greater than 4 days. The system components typically comprise a cannula adapted for subcutaneous insertion into a diabetic patient. The system further comprises a fluid conduit adapted to deliver the insulin solution from a medication reservoir to the site of infusion and a depot in operable contact with the fluid conduit. The depot comprises selected materials including a site-loss mitigating agent (such as heparin) which inhibits inflammation at the site of infusion, and encapsulation of the cannula at the site of infusion. The site-loss mitigating agent is not premixed with the insulin, and instead is adapted to contact the insulin solution in the depot as the insulin solution flows from the medication reservoir to the site of infusion.

A drug delivery device according to an embodiment may include a body including an opening; a magnetic element disposed in the body; a reservoir disposed in the body, connected to the magnetic element, and configured to store a drug; and an opening/closing structure coupled to the body and configured to open or close the opening.

The present invention provides an inhalation device with which it is possible to improve usability and promote users' safety and satisfaction with the inhalation device. An inhalation device according to the present invention is provided with a first member and a second member which is configured to be capable of being attached to and detached from the first member. This inhalation device includes: an active functional part which is provided to the first member; a passive functional part which is provided to the second member and which is capable of changing the state thereof according to the working of the active functional part; a sensor part which is provided to the first member and which detects a changed state of the passive functional part; and a control part which, on the basis of the detected state, determines whether the second member has been attached to the first member.

A portable oscillator of positive expiratory pressure having capability for oscillating indication, the portable oscillator of positive expiratory pressure comprises a shell, an oscillation element and an indicator element; the shell has a pressurized cavity, the oscillation element has a valve to close the pressurized cavity, the indicator element is used to respond an oscillating state of the oscillation element and a static state of the oscillation element; wherein the shell and the oscillation element are respectively provided with a first magnetic element and a second magnetic element; when an expiratory airflow through the pressurized cavity drives the oscillation element to rotate, the valve will separate from the pressurized cavity to release the pressure, a distance between the first magnetic element and the second magnetic element is simultaneously shortened to quickly respond to a repulsive force which is generated between the same poles, and therefore the oscillation element can be returned to an original position; when the valve recloses the pressurized cavity, the pressurized cavity will produce an exhalation resistance.

A connector interface system includes a cap to connect to a reservoir to form a reservoir/cap unit for installation into an infusion pump device. The cap has at least one receptacle for receiving one or more detectable features comprising at least one disc-shaped member, for detection by at least one sensor element on the infusion pump device when the reservoir of the reservoir/cap unit is received in a reservoir receptacle of the infusion pump device. The at least one detectable feature has at least one detectable parameter that is associated with one or more characteristics of the cap, the reservoir, the infusion pump device, a cannula associated with the cap or a tubing connected between the cap and the cannula.

An anti-fouling surface having micron scale pillars embedded with Fe.sub.3O.sub.4 nanoparticles is designed. The pillars may be repeatedly induced to move according to a predetermined frequency, such as one that mimic that of the beating movement of natural cilia, through the application of a magnetic field. When square-shaped pillars with a height of 10 μm, width of 2 μm, and inter-pattern distance of 5 μm actuated for three minutes, more than 99.9 percent of biofilm cells were detached and via gentle rinsing from the surface having the pillars. The anti-fouling surface enables effective prevention of biofilm formation and removal of established biofilms, and can be applied to a broad spectrum of polymers.

Methods and systems are provided for aerosolization of individual building blocks of medical microrobots and subsequent in situ assembly into microrobots capable of medical intervention deep within lung tissues of a subject. The methods and systems of the disclosure may allow for microrobot-based therapy of pulmonary diseases that have previously been difficult to effectively treat using conventional therapeutic approaches.